News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Megan Kruse, MD

Articles by Megan Kruse, MD

Megan Kruse, MD, Discusses the Use of Biosimilars in Breast Cancer Treatment

ByMegan Kruse, MD

December 17th 2019

The hematology and medical oncology expert described the implementation of biosimilars into treating patients with breast cancer.

Latest Updated Articles

Megan Kruse, MD, Discusses the Use of Biosimilars in Breast Cancer Treatment
December 17th 2019

Trending on CancerNetwork

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

Zenocutuzumab Earns FDA National Priority Voucher in Cholangiocarcinoma

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)